SCHEMBL27019991

SCHEMBL27019991

CC(C)/C=C1\C(=O)C(C)(C)CCN1C(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 1/20 0.36
▸ GRIN2B Q13224 1/20 0.36
▸ GRIN2C Q14957 1/20 0.36
▸ NFKB1 P19838 3/20 0.32
▸ NFKB2 Q00653 3/20 0.32
▸ RELA Q04206 3/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ BUB1 O43683 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ TSHR P16473 2/20 0.31
▸ USP2 O75604 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ HTT P42858 2/20 0.30
▸ ATM Q13315 1/20 0.30
▸ NR1H2 P55055 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29882398 0.82 KDM1A (0.39) KDM1AGRIN2BGRIN2CALDH1A1MAPT
SCHEMBL23608365 0.82 KDM1A (0.39) KDM1AGRIN2BGRIN2CALDH1A1MAPT
SCHEMBL479856 0.75 KDM1A (0.43) KDM1AGRIN2BGRIN2CALDH1A1MAPT
SCHEMBL21408124 0.70 KDM1A (0.41) KDM1AALDH1A1MAPTBUB1LMNA
SCHEMBL16903459 0.68 TSHR (0.36) ALDH1A1MAPTLMNATSHRUSP2
SCHEMBL3733424 0.68 KDM1A (0.42) KDM1AGRIN2BGRIN2CALDH1A1MAPT
SCHEMBL31498912 0.68 NR1H2 (0.34) KDM1AGRIN2BGRIN2CBUB1NR1H2
SCHEMBL17459686 0.68 BRD4 (0.35) GRIN2BGRIN2CNFKB1NFKB2RELA
SCHEMBL23609353 0.68 NR1H2 (0.34) KDM1AGRIN2BGRIN2CBUB1NR1H2
SCHEMBL17459688 0.68 BRD4 (0.35) GRIN2BGRIN2CNFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018157-A1 CYCLIC COMPOUNDS AND METHODS OF USING SAME SCHRÖDINGER, INC. 2024-01-18 — — US disclosed
US-20240018157-A1 CYCLIC COMPOUNDS AND METHODS OF USING SAME SCHRÖDINGER, INC. 2024-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018157-A1 CYCLIC COMPOUNDS AND METHODS OF USING SAME MALT1, FKBP1B, FKBP1A KDM1A 1462/4885GRIN2B 4486/4885GRIN2C 4447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback